1. Home
  2. ABVX vs DHC Comparison

ABVX vs DHC Comparison

Compare ABVX & DHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABVX
  • DHC
  • Stock Information
  • Founded
  • ABVX 2013
  • DHC 1998
  • Country
  • ABVX France
  • DHC United States
  • Employees
  • ABVX N/A
  • DHC N/A
  • Industry
  • ABVX
  • DHC Real Estate Investment Trusts
  • Sector
  • ABVX
  • DHC Real Estate
  • Exchange
  • ABVX Nasdaq
  • DHC Nasdaq
  • Market Cap
  • ABVX 722.3M
  • DHC 629.7M
  • IPO Year
  • ABVX N/A
  • DHC N/A
  • Fundamental
  • Price
  • ABVX $7.76
  • DHC $2.41
  • Analyst Decision
  • ABVX Strong Buy
  • DHC Hold
  • Analyst Count
  • ABVX 6
  • DHC 3
  • Target Price
  • ABVX $38.67
  • DHC $4.50
  • AVG Volume (30 Days)
  • ABVX 123.5K
  • DHC 856.3K
  • Earning Date
  • ABVX 09-09-2024
  • DHC 11-04-2024
  • Dividend Yield
  • ABVX N/A
  • DHC 1.66%
  • EPS Growth
  • ABVX N/A
  • DHC N/A
  • EPS
  • ABVX N/A
  • DHC N/A
  • Revenue
  • ABVX $9,676,417.00
  • DHC $1,477,343,000.00
  • Revenue This Year
  • ABVX $31.67
  • DHC N/A
  • Revenue Next Year
  • ABVX $1,189.66
  • DHC $5.26
  • P/E Ratio
  • ABVX N/A
  • DHC N/A
  • Revenue Growth
  • ABVX 100.87
  • DHC 6.62
  • 52 Week Low
  • ABVX $7.11
  • DHC $2.19
  • 52 Week High
  • ABVX $17.02
  • DHC $4.24
  • Technical
  • Relative Strength Index (RSI)
  • ABVX 40.45
  • DHC 39.32
  • Support Level
  • ABVX $7.11
  • DHC $2.37
  • Resistance Level
  • ABVX $8.18
  • DHC $2.50
  • Average True Range (ATR)
  • ABVX 0.44
  • DHC 0.10
  • MACD
  • ABVX -0.00
  • DHC 0.02
  • Stochastic Oscillator
  • ABVX 44.24
  • DHC 40.24

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. They are evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two most common forms are UC and CD.

About DHC Diversified Healthcare Trust of Beneficial Interest

Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. It operates through two segments: Office Portfolio and SHOP. The office portfolio includes medical office properties leased to medical-related businesses and life sciences properties. The SHOP segment runs communities that offer multiple types of residential care, ranging from independent living to nursing services. DHT operates across the United States and the majority of its revenue derives from rents and medical programs.

Share on Social Networks: